The Government has published its full response on the Cumberlege Review on the safety of medicines and medical devices.
NHS England has announced an Innovative Medicines Fund to fast-track promising new medicines.
The government has published a new Innovation Strategy to cement the UK’s position as a world leader in science and research.
The Medicines and Healthcare products Regulatory Agency (MHRA) has published its Delivery Plan for a new era of the agency.
The UK medicines regulator, the MHRA, has today approved Johnson & Johnson's single-dose vaccine for COVID-19. It becomes the fourth vaccine approved for use in the UK.
The MHRA has awarded the first 'innovation passport' under a new scheme to reduce the time for innovative medicines to get to market.
The Accelerated Access Collaborative has published its annual report and confirmed Matt Whitty as AAC Chief Executive.
The Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca’s Covid-19 vaccine for use.
The first vaccine for COVID-19 has been approved for use by the UK's independent regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA) today.
The ABPI welcomes the publication of today's consultation on NICE's Methods and the launched of a public consultation on proposals for changes to the methods it uses to develop its guidance on medicines, medical devices and diagnostics.